Trials / Completed
CompletedNCT02967757
In-market Utilisation of Liraglutide Used for Weight Management in Europe
In-market Utilisation of Liraglutide Used for Weight Management in Europe: a Retrospective Medical Record Review Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 316 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liraglutide | Patients will be treated according to routine clinical practice at the discretion of the treating physician. The study will gather data over the course of routine treatment for liraglutide 3.0 mg and liraglutide 1.2 mg/1.8 mg treated patients |
Timeline
- Start date
- 2016-12-22
- Primary completion
- 2019-05-28
- Completion
- 2019-05-28
- First posted
- 2016-11-18
- Last updated
- 2023-01-20
Locations
19 sites across 2 countries: Germany, Italy
Source: ClinicalTrials.gov record NCT02967757. Inclusion in this directory is not an endorsement.